BioTest4U
Generated 5/11/2026
Executive Summary
BioTest4U is a US-based contract research organization (CRO) headquartered in San Diego, specializing in preclinical oncology and drug development services. Founded in 2014, the company provides a comprehensive suite of in vitro and in vivo assays to support biotech, pharma, and food industry clients in evaluating anti-cancer compounds, metastatic progression, and anti-tumor immunity. Its core offerings include advanced tumor models, drug sensitivity testing, circulating tumor cell isolation, and a range of analytical and imaging services. By enabling precise preclinical evaluation, BioTest4U helps de-risk drug development pipelines and accelerate the translation of novel cancer therapies to the clinic. The company operates in the rapidly growing preclinical CRO market, driven by increasing R&D spending in oncology and the demand for specialized, high-quality contract services.
Upcoming Catalysts (preview)
- Q4 2026Expansion into immuno-oncology assay portfolio60% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)